I<sub>2</sub>-TBHP-catalyzed one-pot highly efficient synthesis of 4,3-fused 1,2,4-triazoles from N-tosylhydrazones and aromatic N-heterocycles via intermolecular formal 1,3-dipolar cycloaddition
I2-TBHP-catalyzed azomethine imine generation and subsequent regioselective 1,3-dipolarcycloaddition (DC) with aromatic N-heterocycles was developed to afford various 4,3-fused 1,2,4-triazoles in excellent yields. The method is operationally simple and highly efficient with broad functional group tolerance.
A facile and efficient approach to access 1,2,4‐triazolo[4,3‐a]pyridines and related heterocycles has been accomplished through condensation of readily available aryl hydrazines with corresponding aldehydes followed by iodine‐mediated oxidative cyclization. This transition‐metal‐free synthetic process is broadly applicable to a variety of aromatic, aliphatic, and α,β‐unsaturated aldehydes, and can
通过容易获得的芳基肼与相应的醛缩合,然后由碘介导的氧化环化反应,可以轻松而有效地获得1,2,4-三唑并[4,3- a ]吡啶和相关杂环。这种无过渡金属的合成方法广泛适用于各种芳香族,脂肪族和α,β-不饱和醛类,并且可以以克为单位方便地进行。
The Preparation of 3-Phenyl[1,2,4]triazolo[4,3-<i>a</i>]pyridines and Their Benzologs from<i>N</i>-(Phenylsulfonyl)benzohydrazonoyl Chloride and Pyridines
作者:Suketaka Ito、Akikazu Kakehi、Toshiyuki Matsuno、Jun-ichi Yoshida
DOI:10.1246/bcsj.53.2007
日期:1980.7
3-Phenyl[1,2,4]triazolo[4,3-a]pyridines were obtained in good yields from N′-[α-(1-pyridinio)benzylidene]benzenesulfonohydrazidates, generated from 2-unsubstituted pyridines and N-(phenylsulfonyl)benzohydrazonoyl chloride (2), by oxidation with chloranil. The reaction of quinoline and isoquinoline with 2 gave 1-phenyl-3-phenylsulfonyl-3,3a-dihydro[1,2,4] triazolo [4,3-a]quinoline and 3-phenyl-1-phenylsulfonyl-1
The use of fused 1,2,4-triazoles for modulating the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments has been described. The present compounds are modulators and more specifically inhibitors of the activity of 11βHSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.
The use of fused 1,2,4-triazoles for modulating the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments has been described. The present compounds are modulators and more specifically inhibitors of the activity of 11βHSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.